Related Tags >> Phase II Novartis milestones Deals

Hepatitis C News

Most Popular Hepatitis C Story

SciClone's hep C drug fails late-stage trial

November 5, 2008 — 11:52am ET | By John Carroll

SciClone Pharmaceuticals' late-stage therapy for hepatitis C failed to hit a primary endpoint in a late-stage trial. The drug, thymalfasin, failed to register a significant response in patients who... Read more...

Hepatitis C Press Releases

Public Statement on Viraferon (Interferon Alfa-2b) Withdrawal of the Marketing Authorisation in the European Union
Hepatitis C Therapeutic DNA Vaccine Delivered By Inovio Biomedical's Electroporation Technology Reduces Viral Load By Up To 99.7
GlobeImmune Hepatitis C Therapeutic Vaccine, GI-5005, Doubles Viral Clearance and Increases RVR Rates in Phase 2 Clinical Trial
Tibotec Presents Interim Findings for TMC435, an Investigational Genotype 1 Hepatitis C Treatment, at the AASLD Liver Meeting 20
GlaxoSmithKline to Acquire Genelabs Technologies to Increase Focus on Novel Small Molecule Therapies for Hepatitis C

Latest Headlines

SciClone's hep C drug fails late-stage trial
November 5, 2008
GSK buys Genelabs for $57M
October 30, 2008
Vertex readies new Phase 3 trial of telaprevir
August 19, 2008
Metabasis strikes $203M pact with Roche
August 8, 2008
Schering-Plough posts positive hep C data
August 4, 2008
Vertex shares rise on positive data for telaprevir
June 9, 2008
Tercica shares skyrocket following takeover bid
June 6, 2008
First miRNA drug enters human studies
May 28, 2008
Valeant chops workforce in restructuring
May 2, 2008
ALSO NOTED: Isotechnika reports psoriasis success; Romark enrolls hep C patients; and much more...
April 18, 2008
Vertex shares jump on positive telaprevir data
April 1, 2008
Vertex drug improves lung function in IIa CF trial
March 27, 2008
C&L: Opexa CEO to retire
March 26, 2008
Presidio snags preclinical hep C program for $108M
March 20, 2008
ALSO NOTED: Rumor Mill: AstraZeneca a possible Shire suitor; Cardiome baits hook for partners; Vertex shares keep sliding; and
March 18, 2008
Valeant shares jump on epilepsy trial data
February 13, 2008
SciClone report positive hep C data
February 11, 2008
Idenix reports success in early-stage HIV drug trial
February 7, 2008
Turbulent market forces Biolex to scrap IPO
February 4, 2008
Phenomix outlines its shot at an IPO
January 28, 2008

Paid Research Reports